Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial
-
Publication Type:Journal article
-
Publication Sub Type:article
-
Authors:Ledermann JA, Embleton AC, Raja F, Perren TJ, Jayson GC, Rustin GJS, Kaye SB, Hirte H, Eisenhauer E, Vaughan M, Friedlander M, González-Martín A, Stark D, Clark E, Farrelly L, Swart AM, Cook A, Kaplan RS, Parmar MKB
-
Publication date:03/2016
-
Pagination:1066, 1074
-
Journal:The Lancet
-
Volume:387
-
Article number:10023
-
Print ISSN:0140-6736
-
Language:en
-
Notes:shorttitle: Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6) urldate: 2016-03-11 file: Ledermann et al. - 2016 - Cediranib in patients with relapsed platinum-sensi.pdf:C\:\Users\rmjlaem\AppData\Roaming\Zotero\Zotero\Profiles\6n70g476.default\zotero\storage\DVJ4QCIK\Ledermann et al. - 2016 - Cediranib in patients with relapsed platinum-sensi.pdf:application/pdf
Abstract
No abstract found
› More search options
UCL Researchers
Show More